Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype
- 9 January 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 68 (2), 110-115
- https://doi.org/10.1212/01.wnl.0000252798.25690.76
Abstract
Background: Pompe disease (acid maltase deficiency, glycogen storage disease type II; OMIM 232300) is an autosomal recessive lysosomal storage disorder characterized by acid α-glucosidase deficiency due to mutations in the GAA gene. Progressive skeletal muscle weakness affects motor and respiratory functions and is typical for all forms of Pompe disease. Cardiac hypertrophy is an additional fatal symptom in the classic infantile subtype. c.-32-13T→G is the most common mutation in adults. Objective: To delineate the disease variation among patients with this mutation and to define the c.-32-13T→G haplotypes in search for genotype–phenotype correlations. Methods: We studied 98 compound heterozygotes with a fully deleterious mutation (11 novel mutations are described) and the common c.-32-13T→G mutation. Results: All patients were Caucasian. None had the classic infantile form of Pompe disease. The clinical course varied far more than anticipated (age at diagnosis GAA gene. In 76% of the cases, c.-32-13T→G was encountered in the second most common GAA core haplotype (DHRGEVVT). In only one case was c.-32-13T→G encountered in the major GAA core haplotype (DRHGEIVT). Conclusion: Patients with the same c.-32-13T→G haplotype (c.q. GAA genotype) may manifest first symptoms at different ages, indicating that secondary factors may substantially influence the clinical course of patients with this mutation.Keywords
This publication has 21 references indexed in Scilit:
- Mutation profile of theGAA gene in 40 Italian patients with late onset glycogen storage disease type IIHuman Mutation, 2006
- Benign course of glycogen storage disease type IIb in two brothers: Nature or nurture?Muscle & Nerve, 2005
- Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patientsBrain, 2005
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePEDIATRICS, 2003
- Evidence for a Founder Effect in Sicilian Patients with Glycogen Storage Disease Type IIHuman Heredity, 2000
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal α‐glucosidase geneClinical Genetics, 1998
- Mutation Detection in Glycogen Storage Disease Type II by RT-PCR and Automated SequencingBiochemical and Biophysical Research Communications, 1997
- A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II)Human Molecular Genetics, 1996
- Genotype‐phenotype correlation in adult‐onset acid maltase deficiencyAnnals of Neurology, 1995